Tao Gao
Tao Gao
Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
Search for other papers by Tao Gao in
Google Scholar
PubMed
Search for other papers by Tao Gao in
Google Scholar
PubMed
Rui Liu
Rui Liu
Department of Oncology. The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
Search for other papers by Rui Liu in
Google Scholar
PubMed
Search for other papers by Rui Liu in
Google Scholar
PubMed
Chunli Li
Chunli Li
Institute of Life Sciences, Chongqing Medical University, Chongqing, China
Search for other papers by Chunli Li in
Google Scholar
PubMed
Search for other papers by Chunli Li in
Google Scholar
PubMed
Xinglin Chu
Xinglin Chu
Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
Search for other papers by Xinglin Chu in
Google Scholar
PubMed
Search for other papers by Xinglin Chu in
Google Scholar
PubMed
Qiao Guo
Qiao Guo
Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
Search for other papers by Qiao Guo in
Google Scholar
PubMed
Search for other papers by Qiao Guo in
Google Scholar
PubMed
Dazhi Ke
Dazhi Ke
Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
Search for other papers by Dazhi Ke in
Google Scholar
PubMed
Search for other papers by Dazhi Ke in
Google Scholar
PubMed
no significant difference in sex composition, age, and TG, HDL-C, FBG, HbA1c, AST and ALT levels between the two groups. Blood pressure, BMI, carotid intima–media thickness and TC, LDL-C, GGT, ALP, and ET-1 levels were higher in patients with
Melody Lok-Yi Chan
Melody Lok-Yi Chan
Department of Medicine, University of Hong Kong, Hong Kong SAR
Search for other papers by Melody Lok-Yi Chan in
Google Scholar
PubMed
Search for other papers by Melody Lok-Yi Chan in
Google Scholar
PubMed
Sammy Wing-Ming Shiu
Sammy Wing-Ming Shiu
Department of Medicine, University of Hong Kong, Hong Kong SAR
Search for other papers by Sammy Wing-Ming Shiu in
Google Scholar
PubMed
Search for other papers by Sammy Wing-Ming Shiu in
Google Scholar
PubMed
Ching-Lung Cheung
Ching-Lung Cheung
Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong SAR
Search for other papers by Ching-Lung Cheung in
Google Scholar
PubMed
Search for other papers by Ching-Lung Cheung in
Google Scholar
PubMed
Anskar Yu-Hung Leung
Anskar Yu-Hung Leung
Department of Medicine, University of Hong Kong, Hong Kong SAR
Search for other papers by Anskar Yu-Hung Leung in
Google Scholar
PubMed
Search for other papers by Anskar Yu-Hung Leung in
Google Scholar
PubMed
Kathryn Choon-Beng Tan
Kathryn Choon-Beng Tan
Department of Medicine, University of Hong Kong, Hong Kong SAR
Search for other papers by Kathryn Choon-Beng Tan in
Google Scholar
PubMed
Search for other papers by Kathryn Choon-Beng Tan in
Google Scholar
PubMed
below 8% for IDOL and PCSK9. Since IDOL is an intracellular protein, we have performed in vitro experiments to confirm that IDOL can be secreted. IDOL was measured in cell culture media of HepG2 cells with or without LXR activation by competitive ELISA
Charlotte Höybye
Charlotte Höybye
Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Beverly M K Biller
Beverly M K Biller
Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Jean-Marc Ferran
Jean-Marc Ferran
Qualiance ApS, Copenhagen, Denmark
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Murray B Gordon
Murray B Gordon
Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Nicky Kelepouris
Nicky Kelepouris
US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Navid Nedjatian
Navid Nedjatian
Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Anne H Olsen
Anne H Olsen
Epidemiology, Novo Nordisk A/S, Soborg, Denmark
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Matthias M Weber
Matthias M Weber
Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
) cholesterol, C-reactive protein, diastolic blood pressure and carotid intima-media thickness), as well as reducing CV risk estimates and improving patients’ quality of life ( 5 , 8 , 9 ). Although GH replacement therapy may initially impair glucose
